News | December 15, 2022
Kerala Ayurveda receives US patent for its herbal formulation
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The investment will enable the company to enter European markets as well as enhance margins in current markets
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Subscribe To Our Newsletter & Stay Updated
